CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US


  • Products Id :- GDHC0078CHR
  • |
  • Pages: 169
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-US

Summary

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape-US". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the US. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the US. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the US, and includes-

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market (Johnson & Johnson, Pfizer, Amgen, Merck, and Abbvie) and profiles and SWOT analyses of the major players in the medical device market (Abbott, GE Healthcare, DePuy, Zimmer and Edwards)

- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of the US

- Porter's five forces analysis for pharmaceutical and medical devices market of the US

- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices

- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the US healthcare market.

Reasons to buy

This report will enhance your decision-making capability by allowing you to-

- Develop business strategies by understanding the trends shaping and driving the US healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

- Identify, understand, and capitalize on the opportunities and challenges in the US healthcare market.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary

Overview of Pharmaceutical Market

Overview of Medical Device Market

Deals Analysis

Porter's Five Forces Model

Market Access

Country Healthcare Landscape

Opportunities and Challenges

Appendix

List of Figures

Figure 1: Pharmaceutical Market, US, Revenue, 2015-2022 8

Figure 2: Medical Device Market, US, Revenue, 2015-2020 8

Figure 3: Number of Deals (2017-2018) 12

Figure 4: 2017-2018 Deal Overview By Region 12

Figure 5: Country Profile, US, 2018 14

Figure 6: Pharmaceutical Market, US, Revenue, 2010-2017 16

Figure 7: Pharmaceutical Market, US, Revenue Forecast, 2018-2022 16

Figure 8: Pharmaceutical Market, US, Pharmaceutical Exports 17

Figure 9: Pharmaceutical Market, US, Top Export Partners 17

Figure 10: Pharmaceutical Market, US, Pharmaceutical Imports 18

Figure 11: Pharmaceutical Market, US, Top Import Partners 18

Figure 12: Pharmaceutical Market, US, Supply Channels 21

Figure 13: Pharmaceutical Market, US, Drug Supply Chain Security Act: Implementation Timeline, 2013-2023 22

Figure 14: Pharmaceutical industry: Supply Chain Vulnerability, US 22

Figure 15: Pharmaceutical Market, US, Major Drugs Going Off-Patent, US, 2018-2022 24

Figure 16: Pharmaceutical Market, US, Generic Full Drug Approvals, US, 2013-2018* 25

Figure 17: Pharmaceutical Market, US, Key Generic Drug Approvals (Jan 18-Aug 18), 2018 26

Figure 18: Pharmaceutical Market, US, Top Selling Biologics Drugs, Sales, 2017 27

Figure 19: Pharmaceutical Market, US, Patent Expirations of Major Biologics, US, 2013-2028 28

Figure 20: Pharmaceutical Market, US Sales (Current and Forecast), Biologics Drugs Going Off-Patent, 2019-2021 29

Figure 21: Pharmaceutical Market, US, Number of Biosimilars Drug Approvals by EMA and USFDA, 2012-2018 30

Figure 22: Pharmaceutical Market, US, Key Events: Biosimilars Breakthroughs and Drug Approvals by EMA and FDA, 2001-2018 30

Figure 23: Pharmaceutical Market, US, Number of Biologics and Biosimilars Drug Approvals, USA, 2012-2018 (June 18) 31

Figure 24: Pharmaceutical Market, US, Biosimilars Approvals, 2017-2018 32

Figure 25: Pharmaceutical Market, Sales of OTC Products Based on Therapeutic Areas by Value and Volume (USD million), US, 2016 33

Figure 26: Pharmaceutical Market, US, Sales of Patented Drug Products by Major Therapeutic Class, 2015 34

Figure 27: Pharmaceutical Market, US, Major Players 36

Figure 28: Medical Device Market, US, Revenue, 2015-2020 53

Figure 29: Medical Device Market, US, Revenue Forecast, 2021-2025 53

Figure 30: Medical Device Market, US, Revenue by Segment, 2017 54

Figure 31: Orthopedic Devices Market, US, Revenue 55

Figure 32: Orthopedic Devices Market, US, Market Share of Major Players 55

Figure 33: Cardiovascular Devices Market, US, Revenue 56

Figure 34: Cardiovascular Devices Market, US, Market Share of Major Players 56

Figure 35: In Vitro Diagnostics Devices Market, US, Revenue 57

Figure 36: In Vitro Diagnostics Devices Market, US, Market Share of Major Players 57

Figure 37: Healthcare IT Market, US, Revenue 58

Figure 38: Healthcare IT Market, US, Market Share of Major Players 58

Figure 39: Ophthalmic Devices Market, US, Revenue 59

Figure 40: Ophthalmic Devices Market, US, Market Share of Major Players 59

Figure 41: Diagnostic Market, US, Revenue (USD bn), 2010-2017 60

Figure 42: Diagnostic Market, US, Revenue Forecast (USD bn), 2018-2022 60

Figure 43: Medical Device Market, US, Revenue of Major Players, 2016 60

Figure 44: Deal Value and Deal Count, Pharmaceutical Market, US, 2017-2018 82

Figure 45: Deal Value and Deal Count Quarterly, Pharmaceutical Market, US, 2017-2018 82

Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, US, 2017-2018 82

Figure 47: Top Five Therapy Area by Deal Value, Pharmaceutical Market, US, 2017-2018 83

Figure 48: Top Five Therapy Area by Deal number, Pharmaceutical Market, US, 2017-2018 83

Figure 49: M&A Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018 83

Figure 50: Venture Financing Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018 83

Figure 51: Private Equity Deals by Therapy Area, Pharmaceutical Market, US, 2017-2018 83

Figure 52: Medical Device Market Deals, US, 2017-2018 (by deal value, USD m) 84

Figure 53: Medical Device Market Deals, US, 2017- 2018 (by deal count) 84

Figure 54: Medical Device Market Deals Share (by deal count), US, 2017-2018 84

Figure 55: Medical Device Market Deals Share (by deal value), US, 2017-2018 84

Figure 56: Medical Device, Top Therapy Area by Deal Value, US, 2017-2018 85

Figure 57: Medical Device, Top Therapy Area by Deal Number, US, 2017-2018 85

Figure 58: M&A Deals by Therapy Area, Medical Device, US, 2017-2018 (by value and by number) 85

Figure 59: Venture Financing Deals by Therapy Area, Medical Device, US, 2017-2018 (by value and by number) 85

Figure 60: Private Equity Deals by Therapy Area, Medical Device US, 2017-2018 (by value and by number) 85

Figure 61: Healthcare System, Structure and Flow of Funds, US, 2018 90

Figure 62: Overview of Public and Private Insurance Provider, US, 2018 91

Figure 63: Components of Medicare Plan, Public Insurance, US, 2018 93

Figure 64: Doughnut Hole and Medicare Part D Coverage Gap, US, 2018 94

Figure 65: Premiums and Deductibles, Medicare, US, 2018 95

Figure 66: Features of Medicare and Medicaid Plan, US, 2018 96

Figure 67: Recent Advancements in Healthcare, DVA, US, 2016-2018 98

Figure 68: Overview of Private Insurance Plans, US, 2018 101

Figure 69: Various Types of Managed Care Plans, US, 2018 102

Figure 70: Major Components of National Health Expenditure (%), US, 2016 103

Figure 71: Overview of Affordable Care Act and American Health Care Act, US 105

Figure 72: Uninsured Rate, US, 2013-2018 106

Figure 73: OOP Expenditure (% of Total Expenditure on Health), US, 2010-2017 107

Figure 74: OOP Expenditure (OOP Expenditure per Capita), US, 2010-2017 107

Figure 75: Annual Rate of Change (%), Average Price of Prescription Drugs, US, 2010-2017 108

Figure 76: Pricing List at Different supply Chain Levels, US, 2018 109

Figure 77: FDA, Organizational Structure, US, 2018 111

Figure 78: Outline of the Clinical Development Process for a New Drug, US, 2017 112

Figure 79: Outline of Clinical Development Process for Generic Drug, US 117

Figure 80: Outline of Biological Products Licensure Process, US, 2018 119

Figure 81: Medical Device Approval Process, US, 2016 121

Figure 82: Patent Approval Process, US, 2018 125

Figure 83: Trademark Approval Process, US, 2018 126

Figure 84: Number of Hospitals, US, 2010-2017 133

Figure 85: Number of Ambulatory Surgery Centers (ASCs), US, 2010-2017 133

Figure 86: CT Scanners and MRI Units (per million population), US, 2010-2017 134

Figure 87: Mammography Units (per million population), US, 2010-2017 134

Figure 88: Hospital Beds (per 1,000 population), US 135

Figure 89: Acute Care Hospital Beds (per 1,000 population), US 135

Figure 90: Psychiatric Hospital Beds (per 1,000 population), US 135

Figure 91: Life Expectancy, 2010-2017, US 136

Figure 92: Elderly population (% of total population), 2010-2017, US 136

Figure 93: Immunization Rate (%), DPT, 2010-2017, US 137

Figure 94: Immunization Rate (%), Measles, 2010-2017, US 137

Figure 95: PM2.5 (?g per m3), US, 2010-2016 138

Figure 96: CO2 Emissions (million tons), US, 2010-2016 138

Figure 97: Physicians (per 1,000 population), US, 2010-2016 139

Figure 98: Nurses (per 1,000 population), US, 2010-2016 139

Figure 99: Dentists (per 1,000 population), US, 2010-2016 139

Figure 100: Pharmacists (per 1,000 population), US, 2010-2016 139

Figure 101: Major Causes of Mortality (per 1,000 population), US, 2015 140

Figure 102: Major Causes of Male Mortality, US, 2015 140

Figure 103: Major Causes of Female Mortality, US, 2015 140

Figure 104: Disability-Adjusted Life Years by Major Disease (000), US, 2016 140

Figure 105: Healthcare Expenditure as Percentage of GDP (%), US, 2010-2017 141

Figure 106: Public-Private Share (%), US, 2010-2017 141

Figure 107: Major Components of Healthcare Spending (%), US, 2016 142

Figure 108: Opportunities and Challenges, US 146

List of Tables

Table 1: Average Gross Margin (%) on Various Drug Categories for Each Sector, Weighted by US Sales, 2015 21

Table 2: Pharmaceutical Market, Major Drugs Going Off-Patent, US Sales, 2017 24

Table 3: Pharmaceutical Market, Key Biologics Approval, US, 2018 (Jan 18-Aug 18) 27

Table 4: Pharmaceutical Market, US, Sales of Patented Drug Products by Major Therapeutic Class (USD bn), 2015 34

Table 5: Medical Device Market, US, Revenue by Segment 54

Table 6: Orthopedic Devices Market, US, Revenue and Market Share of Major Players 55

Table 7: Cardiovascular Devices Market, US, Revenue and Market Share of Major Players 56

Table 8: In Vitro Diagnostics Devices Market, US, Revenue and Market Share of Major Players 57

Table 9: Healthcare IT Market, US, Revenue and Market Share of Major Players 58

Table 10: Ophthalmic Devices Market, US, Revenue and Market Share of Major Players 59

Table11: Overview of Public Insurance Providers, Federal Poverty Plans, US, 2018 99

Table 12: Overview of Public Insurance Providers, Metal Plans, US, 2018 100

Table 13: Overview of Public Insurance Providers, Value of Metal Plans, US, 2018 100

Table 14: Market Authorization for Biopharmaceutical Products, Biosimilar User Fee Act (BsUFA) Fees, 2018-2019, US 120

Table 15: Market Authorization for Medical Devices, Medical Device User Fee Amendments (MDUFA) Fees, 2018-2019, US 122

Table 16: Patent Fees, 2018, US 124

Table 17: Trade Associations, US 143

Table 18: Trade Fairs, US 144

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

US, Pharmaceutical Market, Medical Devices, Drivers and Barriers, Major Players, Regulatory landscape, Reimbursement landscape, Deals, Porter Five Forces,Opportunities and Challenges

select a license
Single User License
USD 1995 INR 143441
Site License
USD 3990 INR 286881
Corporate User License
USD 5985 INR 430322

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com